市場調查報告書
商品編碼
1413858
自動化配混設備市場:按組件、產品類型、應用和最終用戶分類 - 2024-2030 年全球預測Automated Compounding Devices Market by Component (ACD Equipment, ACD Software), Product Type (Intravenous Compounding Systems, Oral Compounding Systems, TPN Compounding Systems), Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年自動配混設備市場規模為23.2億美元,預計2024年將達25.6億美元,2030年將達到46.9億美元,複合年成長率為10.52%。
全球自動配混設備市場
主要市場統計 | |
---|---|
基準年[2023] | 23.2億美元 |
預測年份 [2024] | 25.6億美元 |
預測年份 [2030] | 46.9億美元 |
複合年成長率(%) | 10.52% |
自動配製設備旨在製備用於醫療機構配藥的藥物。自動化調配設備是將不同劑量的藥物混合、稀釋、組裝過程自動化、高精度、安全的設備。自動化調配設備廣泛應用於腫瘤學(化療藥物製備)、全腸外營養(TPN)以及集中製藥設施中常見的批量調配等領域。由於需要在無菌環境中有效且安全地製備藥物,最終用戶主要包括醫院藥局、複方藥局和門診服務。治療越來越多的慢性病的藥物需求不斷增加,以及對個人化醫療的日益關注,正在推動對更多組合藥物的需求。此外,提高醫療保健環境中的藥品安全標準的重要性日益增加,也推動了自動化配製設備的採用。阻礙自動化混配設備市場成長的是自動化混配系統安裝和維護的高成本。需要熟練的專業人員來操作這些複雜的設備,這使得自動化複合設備的實施更加複雜。研究和創新的成長旨在建立可擴展的機械模型,以滿足從小型診所到大型醫院的各種業務規模,預計將為市場成長創造機會。此外,投資研究耐用且易於清洗的材料有助於滿足嚴格的衛生和無菌要求。
區域洞察
美洲自動化配料設備市場深受美國和加拿大醫療基礎設施和法規環境的影響。除了慢性病增加之外,醫療保健自動化正在推廣,以提高配藥的準確性和安全性,對自動化配藥系統的需求也在增加。在歐盟 (EU),嚴格的配藥監管、注重降低醫療成本以及加強藥房和醫院的技術實施推動了市場的發展。德國、法國、英國和義大利等國家處於實施這些設備的最前沿,旨在提高醫療保健品質和病人安全。歐盟有興趣標準化其成員國之間的製藥實踐,促進自動化配製設備的引進,並促進跨境研究和開發舉措。中國、日本、印度等亞太地區是自動配混設備市場前景看好的成長機會。該地區的市場動態是由醫療基礎設施的快速開拓、醫療成本的上升以及對藥品安全的日益關注所推動的。
FPNV定位矩陣
FPNV 定位矩陣對於評估自動化配混設備市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對自動化配混設備市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴考察,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。
3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1-自動配混設備市場的市場規模與預測是多少?
2-在自動化配混設備市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3-自動配混設備市場的技術趨勢與法律規範是什麼?
4-自動化配混設備市場主要供應商的市場佔有率為何?
5-進入自動配混設備市場適合的型態與策略手段有哪些?
[190 Pages Report] The Automated Compounding Devices Market size was estimated at USD 2.32 billion in 2023 and expected to reach USD 2.56 billion in 2024, at a CAGR 10.52% to reach USD 4.69 billion by 2030.
Global Automated Compounding Devices Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.32 billion |
Estimated Year [2024] | USD 2.56 billion |
Forecast Year [2030] | USD 4.69 billion |
CAGR (%) | 10.52% |
The automated compounding devices are designed to prepare medications for dispensing in healthcare settings. These devices automate the process of mixing, diluting, and assembling drugs in various dosages with a high degree of precision and safety. Automated compounding devices are widely used in several areas such as oncology (for chemotherapy drug preparation), total parenteral nutrition (TPN), and high-volume workloads often found in centralized compounding facilities. The end users primarily include hospital pharmacies, compounding pharmacies, and ambulatory services due to their need for efficient and safe preparation of medications in sterile environments. Increased medication needs to manage rising incidences of chronic diseases, along with the rising focus on personalized medicine, fuels demand for more compounded medications. Additionally, the growing importance of improving pharmacological safety standards in healthcare settings incentivizes the adoption of automated compounding devices. High costs associated with the installation and maintenance of automated compounding systems hamper the growth of the automated compounding devices market. The need for skilled professionals to operate these advanced devices further complicates the implementation of automated compounding devices. Growing research and innovation directed toward creating scalable machine models that cater to varying sizes of operations, from small clinics to large hospitals, are expected to create opportunities for market growth. Furthermore, investing in research for materials that are more durable and easy to clean could aid in meeting stringent hygiene and sterility requirements.
Regional Insights
The market for automated compounding devices in the Americas is highly influenced by the healthcare infrastructure and regulatory environment in the United States and Canada. The increasing prevalence of chronic diseases, coupled with a push towards healthcare automation to enable precision and safety in medication dispensing, fuels the need for automated compounding systems. In the European Union, the market is driven by stringent regulations on medication preparation, a focus on reducing healthcare costs, and increasing adoption of technology in pharmacies and hospitals. Countries such as Germany, France, the UK, and Italy are at the forefront of adopting these devices, aiming to improve the quality of care and patient safety. The EU's interest in standardizing pharmaceutical practices across member states augments the implementation of automated compounding devices and fosters cross-border research and development initiatives. The Asia Pacific region, including countries such as China, Japan, and India, presents a promising growth opportunity for the automated compounding devices market. This region's market dynamics are driven by rapidly developing healthcare infrastructure, increasing healthcare expenditure, and a growing focus on medication safety.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Automated Compounding Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Automated Compounding Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Automated Compounding Devices Market, highlighting leading vendors and their innovative profiles. These include Amerisource Bergen Corporation, ARxIUM Inc., B. Braun SE, Baxter Healthcare Corporation, Becton, Dickinson and Company, Cantel Medical Corp., CapsulCN International Co., Ltd., Codonics Inc., Fagron N.V., ForHealth Technologies, Fresenius Kabi AG, Grifols International S.A., Health Robotics SRL, Loccioni Group, McKesson Corporation, Meditecno S.r.l., Medtronic PLC, Omnicell, Inc., Quirem Medical B.V., ScriptPro LLC, Talyst LLC, Tecan Group Ltd., Terumo Corporation, and Yuyama Co., Ltd..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Automated Compounding Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Automated Compounding Devices Market?
3. What are the technology trends and regulatory frameworks in the Automated Compounding Devices Market?
4. What is the market share of the leading vendors in the Automated Compounding Devices Market?
5. Which modes and strategic moves are suitable for entering the Automated Compounding Devices Market?